Phase 2a Study of Baxdrostat in Primary Aldosteronism

By afschroeder • July 15, 2025

Turcu AF, Freeman MW, Bancos I, Ben-Shlomo A, Hamidi O, Hamrahian AH, Huang W, Kirschner LS, Sam R, Mallappa A, Tuyishimire B, Lihn AS, Perl S, Brown MJ; SPARK Investigator Group. Phase 2a Study of Baxdrostat in Primary Aldosteronism. N Engl J Med. 2025 Jul 13. doi: 10.1056/NEJMc2508629. Epub ahead of print. PMID: 40658651.

Tags: Cedars Sinai DoM, Endocrinology, Publications

AI-CVD-AF: A Novel Atrial Fibrillation Prediction Model Based on Coronary Artery Calcium Scans

Mirjalili SR, Atlas K, Reeves AP, Zhang C, Wasserthal J, Azimi A, Hashemi A, Mozafarybazargany M, Atlas T, Henschke CI, Yankelevitz DF, Zulueta JJ, Fan[...]

Are Urologists and/or Radiation Oncologists Biased when Reporting of Advantages and Disadvantages of Surgery versus Radiation in Consultations for Early-Stage Prostate Cancer?

Friedrich NA, Luu M, Gale R, Chaplin A, Polineni R, Shiang A, Shin D, Freedland SJ, Spiegel B, Ballas LK, Kokorowski P, Daskivich TJ. Are[...]

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies

Barry J, Abranches E, Baptista RP, Barry C, Brandsten C, Bruce K, Carpenter MK, Cavagnaro J, Collins L, Csaszar E, Dashnau J, de Villa D,[...]